2 - -4+ 8+ ACTIVATION AND PROTECTION OF T-CELLSCD4+ AND CD8+ USING AN H2 RECEPTOR AGONIST AND OTHER T-CELL ACTIVATING AGENTS

摘要

The present invention provides a method of identifying a patient in need of increased T cell activity, administering to a patient an effective amount of a T cell activating composition, and an effective amount of a compound that inhibits the production or release of intercellular reactive oxygen metabolites (ROM). A method for facilitating T cell activation of a patient, comprising administering to a patient. The invention also relates to augmenting the effectiveness of the vaccine using H ₂ receptor agonists.